» Articles » PMID: 26944461

Vulvodynia: Definition, Prevalence, Impact, and Pathophysiological Factors

Overview
Journal J Sex Med
Date 2016 Mar 6
PMID 26944461
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Vulvodynia constitutes a highly prevalent form of chronic genital pain in women, and current information regarding its definition, prevalence, impact, and pathophysiologic factors involved is needed.

Aim: To update the scientific evidence published in 2010 from the Third International Consultation of Sexual Medicine pertaining to the definition, prevalence, impact, and pathophysiologic factors of women's sexual pain.

Methods: An expert committee, as part of the Fourth International Consultation of Sexual Medicine, comprised of researchers and clinicians from biological and social science disciplines, reviewed the scientific evidence on the definition, prevalence, impact, and pathophysiologic factors related to chronic genital pain.

Main Outcome Measures: A review of the definition, prevalence, impact, and pathophysiological factors involved in vulvodynia.

Results: Vulvodynia is a prevalent and highly impactful genital pain condition. Numerous factors have been implicated in its development and maintenance.

Conclusion: What is becoming increasingly apparent is that it likely represents the end point of different factors that can differ from patient to patient. Longitudinal research is needed to shed light on risk factors involved in the expression of vulvodynia, as well as in potential subgroups of affected patients, in order to develop an empirically supported treatment algorithm.

Citing Articles

Understanding Patient Experiences of Vulvodynia Through Reddit: Qualitative Analysis.

Grutman A, Perelmuter S, Perez A, Meurer J, Contractor M, Mathews E JMIR Infodemiology. 2025; 5:e63072.

PMID: 40048638 PMC: 11906116. DOI: 10.2196/63072.


The Vulvodynia Primary Care Toolkit: results of a mixed-method evaluation with community-based family physicians in British Columbia.

Hunker K, Altas M, Goldsmith K, Farrell J, Bouchard K Fam Pract. 2025; 42(1.

PMID: 39834268 PMC: 11747290. DOI: 10.1093/fampra/cmaf002.


Low-dose naltrexone as a treatment for vulvodynia: A case series.

Sullender R, Silverstein R, Goodwin D, McClurg A, Carey E Case Rep Womens Health. 2025; 45():e00677.

PMID: 39802731 PMC: 11719202. DOI: 10.1016/j.crwh.2024.e00677.


Health and socioeconomic well-being of women with endometriosis and provoked vestibulodynia: Longitudinal insights from Swedish registry data.

Muhlrad H, Olovsson M, Linnros E, Haraldson P, Bohm-Starke N PLoS One. 2024; 19(9):e0307412.

PMID: 39226269 PMC: 11371220. DOI: 10.1371/journal.pone.0307412.


Vulvodynia, Genital Eczema and Lichen Sclerosus: What are the Successful Treatments from a Patient's Perspective?.

Berger V, Fierz R, Kolm I, Leeners B, Betschart C Int J Womens Health. 2024; 16:1337-1347.

PMID: 39108592 PMC: 11302425. DOI: 10.2147/IJWH.S448861.